| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 646395 | Null | 0.0352028253287042 | 0.00705299 |
| NSC 658397 | N-(4-AZIRIDINYLBUTYL)-1,3-DIAMINOPROPANE | 0.0352028253287042 | 0.23515053 |
| NSC 658837 | Null | 0.0352028253287042 | 0.1879964 |
| NSC 678106 | Rhamnazin | 0.0352028253287042 | 0.14944872 |
| NSC 679024 | 1,8-Naphthyridin-4(1H)-one, 2-(4-fluorophenyl)-5-methyl- | 0.0352028253287042 | 0.088273558 |
| NSC 686393 | Null | 0.0352028253287042 | 0.21023694 |
| NSC 689626 | Null | 0.0352028253287042 | 0.19731698 |
| NSC 709358 | 1H-Pyrrole-2-carboxamide, N-[3-(dimethylamino)propyl]-1-methyl-4-[[[1-methyl- 4-[[1-oxo-4-[[(2,3,5,11a-tetrahydro-7-methoxy-5-oxo- 1H-pyrrolo[2,1-c][1,4]benzodiazepin-8-yl]oxy]butyl]amino]- 1H-pyrrol | 0.0352028253287042 | 0.35123961 |
| NSC 718564 | Null | 0.0352028253287042 | 0.077828401 |
| NSC 719667 | 7-methoxy-8-[3-(1,4-oxazinan-4-yl)propoxy-(11aS)-2,3,5,11a -tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-5-one | 0.0352028253287042 | 0.20274627 |